IronNet, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Restatement of Condensed Consolidated Financial Statements - Schedule of the effect of restatement to the Company's financial statements (Details)

Restatement of Condensed Consolidated Financial Statements - Schedule of the effect of restatement to the Company's financial statements (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020	Jul. 31, 2021	Jan. 31, 2021	Jul. 31, 2020	Jan. 31, 2020
Current assets
Accounts receivable	$ 4,675		$ 4,675			$ 1,643
Unbilled receivable	5,064		5,064			1,425
Related party receivables and loan receivables	4,092		4,092			3,599
Account and loan receivables	13,831		13,831			6,667
Total current assets	97,878		97,878			45,667
Total assets	106,181		106,181			51,691
Current liabilities:
Deferred revenue	16,379		16,379			12,481
Total current liabilities	27,933		27,933			21,392
Deferred revenue	17,910		17,910			21,563
Total liabilities	47,383		47,383			46,665
Stockholders' equity
Additional paid-in capital	429,176		429,176			180,853
Accumulated deficit	(370,655)		(370,655)			(175,039)
Total liabilities and stockholders' equity	106,181		106,181			51,691
Operating expenses
Research and development	24,455	$ 5,687	38,917	$ 19,965
Sales and marketing	51,244	7,155	66,095	23,265
General and administrative	79,735	4,715	91,419	16,690
Operating Expenses	155,434	17,557	196,431	59,920
Operating Loss	(150,889)	(12,613)	(183,188)	(43,224)
Loss before income taxes	(162,915)	(12,435)	(195,560)	(43,099)
Benefit (provision) for income taxes	34	19	56	58
Net loss	$ (162,949)	$ (12,454)	$ (195,616)	$ (43,157)
Basic and diluted net loss per common share	$ (1.87)	$ (0.19)	$ (2.64)	$ (0.67)
Cash flows from operating activities
Employee stock based compensation			$ 129,983	$ 27
Changes in operating assets and liabilities:
Accounts receivable			7,163	962
Deferred revenue			(245)	2,689
Net cash used in operating activities			(59,095)	(39,897)
Comprehensive loss	$ (162,646)	$ (12,905)	(195,388)	(43,559)
Stock-based compensation	129,956	(29)	129,983	27
Balance	58,798	3,664	58,798	3,664	$ (27,101)	5,026	$ 14,104	$ 3,069
As Previously Reported
Current assets
Accounts receivable	2,246		2,246
Unbilled receivable	3,885		3,885
Related party receivables and loan receivables	3,521		3,521
Account and loan receivables	9,652		9,652
Total current assets	93,699		93,699
Total assets	102,002		102,002
Current liabilities:
Deferred revenue	12,929		12,929
Total current liabilities	24,483		24,483
Deferred revenue	17,181		17,181
Total liabilities	43,204		43,204
Stockholders' equity
Additional paid-in capital	459,349		459,349
Accumulated deficit	(400,828)		(400,828)
Total liabilities and stockholders' equity	102,002		102,002
Operating expenses
Research and development	28,144		42,606
Sales and marketing	57,196		72,046
General and administrative	100,267		111,952
Operating Expenses	185,607		226,604
Operating Loss	(181,062)		(213,361)
Loss before income taxes	(193,088)		(225,733)
Benefit (provision) for income taxes	34		56
Net loss	$ (193,122)		$ (225,789)
Basic and diluted net loss per common share	$ (2.22)		$ (3.05)
Cash flows from operating activities
Employee stock based compensation			$ 160,156
Changes in operating assets and liabilities:
Accounts receivable			2,984
Deferred revenue			(3,934)
Net cash used in operating activities			(59,095)
Comprehensive loss	$ (192,819)		(225,561)
Stock-based compensation	160,129		160,156
Balance	58,798		58,798
Adjustments
Current assets
Accounts receivable	2,429		2,429
Unbilled receivable	1,179		1,179
Related party receivables and loan receivables	571		571
Account and loan receivables	4,179		4,179
Total current assets	4,179		4,179
Total assets	4,179		4,179
Current liabilities:
Deferred revenue	3,450		3,450
Total current liabilities	3,450		3,450
Deferred revenue	729		729
Total liabilities	4,179		4,179
Stockholders' equity
Additional paid-in capital	(30,173)		(30,173)
Accumulated deficit	30,173		30,173
Total liabilities and stockholders' equity	4,179		4,179
Operating expenses
Research and development	(3,689)		(3,689)
Sales and marketing	(5,952)		(5,951)
General and administrative	(20,532)		(20,533)
Operating Expenses	(30,173)		(30,173)
Operating Loss	30,173		30,173
Loss before income taxes	30,173		30,173
Benefit (provision) for income taxes	0		0
Net loss	$ 30,173		$ 30,173
Basic and diluted net loss per common share	$ 0.35		$ 0.41
Cash flows from operating activities
Employee stock based compensation			$ (30,173)
Changes in operating assets and liabilities:
Accounts receivable			4,179
Deferred revenue			4,179
Comprehensive loss	$ 30,173		30,173
Stock-based compensation	(30,173)		(30,173)
As Restated
Current assets
Accounts receivable	4,675		4,675
Unbilled receivable	5,064		5,064
Related party receivables and loan receivables	4,092		4,092
Account and loan receivables	13,831		13,831
Total current assets	97,878		97,878
Total assets	106,181		106,181
Current liabilities:
Deferred revenue	16,379		16,379
Total current liabilities	27,933		27,933
Deferred revenue	17,910		17,910
Total liabilities	47,383		47,383
Stockholders' equity
Additional paid-in capital	429,176		429,176
Accumulated deficit	(370,655)		(370,655)
Total liabilities and stockholders' equity	106,181		106,181
Operating expenses
Research and development	24,455		38,917
Sales and marketing	51,244		66,095
General and administrative	79,735		91,419
Operating Expenses	155,434		196,432
Operating Loss	(150,889)		(183,188)
Loss before income taxes	(162,915)		(195,560)
Benefit (provision) for income taxes	34		56
Net loss	$ (162,949)		$ (195,616)
Basic and diluted net loss per common share	$ (1.87)		$ (2.64)
Cash flows from operating activities
Employee stock based compensation			$ 129,983
Changes in operating assets and liabilities:
Accounts receivable			7,163
Deferred revenue			(245)
Net cash used in operating activities			(59,095)
Comprehensive loss	$ (162,646)		(195,388)
Stock-based compensation	129,956
Balance	58,798		58,798
Additional Paid-in Capital [Member]
Changes in operating assets and liabilities:
Stock-based compensation	129,956	(29)	129,983	27
Balance	429,176	167,353	429,176	167,353	181,181	180,853	164,929	$ 123,235
Additional Paid-in Capital [Member] \| As Previously Reported
Changes in operating assets and liabilities:
Stock-based compensation	160,129		160,156
Balance	459,349		459,349
Additional Paid-in Capital [Member] \| Adjustments
Changes in operating assets and liabilities:
Stock-based compensation	(30,173)		(30,173)
Balance	(30,173)		(30,173)
Additional Paid-in Capital [Member] \| As Restated
Changes in operating assets and liabilities:
Stock-based compensation	129,956		129,983
Balance	429,176		429,176
Retained Earnings [Member]
Changes in operating assets and liabilities:
Balance	(370,655)	$ (162,823)	(370,655)	$ (162,823)	$ (207,706)	$ (175,039)	$ (150,369)
Retained Earnings [Member] \| As Previously Reported
Operating expenses
Net loss	(193,122)		(225,789)
Changes in operating assets and liabilities:
Balance	(400,828)		(400,828)
Retained Earnings [Member] \| Adjustments
Operating expenses
Net loss	30,173		30,173
Changes in operating assets and liabilities:
Balance	30,173		30,173
Retained Earnings [Member] \| As Restated
Operating expenses
Net loss	(162,949)		(195,616)
Changes in operating assets and liabilities:
Balance	$ (370,655)		$ (370,655)